Immune Technology Corp.
- UEI
- M6JRZ9T1ML65
- CAGE
- 4QD06
- SAM.gov registration
- Expired
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Website
- immune-tech.com
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sbir phase i: monoclonal antibody selecting system and process | National Science Foundation | $99,000 |
Quick answers
Is Immune Technology Corp. registered in SAM.gov?
Immune Technology Corp.'s SAM.gov registration expired on December 14, 2021.
What is Immune Technology Corp.'s most recent federal award?
Immune Technology Corp.'s most recent federal contract award is Drugs and biologicals (HHSN272201500283PC), from NIAID DEA OA Acquisitions (NIH), on August 28, 2015.
On GovTribe
See Immune Technology Corp.'s full federal record
- Federal contract awards
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors